Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence
- PMID: 17124224
- PMCID: PMC1661741 (V体育安卓版)
- DOI: 10.1136/bmj.39000.486701.68
Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence
"VSports手机版" Abstract
Increasing intake of folic acid would be a relatively cheap and simple way of reducing heart disease, if it works VSports手机版. Can we draw a definitive conclusion from the current evidence. .
Conflict of interest statement
Competing interests: ML, NJW, and DSW have interests in a combined pill (polypill) to simultaneously reduce four cardiovascular risk factors including homocysteine V体育安卓版. NJW and ML have patents (granted and pending) on the formulation of the polypill. .
Figures


References (VSports最新版本)
-
- Homocysteine Studies Collaboration. Homocysteine and the risk of ischemic heart disease and stroke. JAMA 2002;288:2015-22. - PubMed
-
- Kluijtmans LAJ, Boers GHD, Kraus JP, van den Heuvel LP, Cruysberg JR, Trijbels FJ, et al. The molecular basis of cystathionine β synthase deficiency in Dutch patients with homocystinuria: effect of SBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet 1999;65:59-67. - PMC - PubMed
Publication types
MeSH terms
- "VSports注册入口" Actions
- Actions (VSports注册入口)
- "V体育官网" Actions
- Actions (V体育平台登录)
- "V体育安卓版" Actions